Recursion Pharmaceuticals Inc - Ordinary Shares - Class A Live Stock Price Today, Share Analysis and Chart

Name: Recursion Pharmaceuticals Inc - Ordinary Shares - Class A: Is Infosys Ltd. worth buying?
Item: Recursion Pharmaceuticals Inc - Ordinary Shares - Class A
Rating: 1.219375125
Author: Trendlyne DVM scores

Momentum Trap

about

Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improvi...

6.26 -0.17 (-2.64%)

49.35% Fall from 52W High

22.7M

XNAS Volume

XNAS 24 Jul, 2025 5:30 PM (EDT)

Low Financial Strength

16.7 / 100

Expensive Valuation

10.7 / 100

Technically Neutral

53.6 / 100

Momentum Trap These stocks are the ones with poor quality and also financials and technical ranging from bad to medium score. This indicates that investors should be highly watchful with these stocks. View Similar Embed DVM

1Yr Price target upside is 7%

6 analysts

Recursion Pharmaceuticals ... Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Recursion Pharmaceuticals Inc - Ordinary Shares - Class A Live Stock Price Today, Share Analysis and Chart

Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improvi...

49.35% Fall from 52W High

SWOT Analysis

Recursion Pharmaceuticals ... Live Price Chart